A Canadian team has found that compounds from sea sponges could be useful for treating cystic fibrosis. The compounds work in part by inhibiting a new family of targets for the disease: poly(ADP-ribose) polymerases. The researchers now plan to work backward to uncover why blocking these polymerases improves the function of CFTR, the mutated protein that causes CF.